Wyeth want to Join with Pfizer
U.S. pharmaceutical company Wyeth, said its shareholders agree to takeover deal by rival Pfizer. so that more and raise the largest drug producer in the world. According to Wyeth, an initial count showed 98 percent of the shareholder vote approving the merger. ”Mergers are the best in the interests of the company and our shareholders,” said Wyeth’s chief executive, Bernard Poussot.
Join with Pfizer, Poussot see opportunities to increase the scale and resources necessary to become the world’s leading biopharmaceutical company and leader in the industry of human and animal health care, both in the prevention or treatment of disease. The combined organization will continue the mission of bringing innovative solutions Wyeth medical patients around the world. Pfizer, the world’s largest pharmaceutical company, announced merger plans in January and looking for diversification in preparation for the termination of patent rights on medicines phenomenal. The total transaction value of U.S. $ 68 billion (48.2 billion euros) seems to be the largest takeover in the global pharmaceutical sector since Pfizer acquired Warner-Lambert Co.. worth U.S. $ 93.4 billion in 2000.
